Paul Roessler Joins Algenol as CSO

July 5, 2012
AlgaeIndustryMagazine.com

Fort  Myers, FL-based Algenol Biofuels Inc. has announced the hiring of Dr. Paul Roessler, Ph.D. as Chief Scientific Officer for the company. “Dr. Roessler is joining Algenol at a very exciting time. His extensive expertise in algal biofuels is a major addition to our pioneering research & development efforts as we move toward commercialization,” said Paul Woods, Algenol’s CEO and co-Founder. Dr. Roessler will oversee all of Algenol’s scientific research and development efforts.

Dr. Roessler has over 30 years of research experience involving the physiology, biochemistry and molecular biology of plants and algae. Prior to joining Algenol, Dr. Roessler was Vice President of Renewable Fuels and Chemicals at Synthetic Genomics, Inc., where he led a program to develop renewable fuels and chemicals from cyanobacteria and other types of algae. His background also includes experience at The Dow Chemical Company, Monsanto, and the Aquatic Species Program of the National Renewable Energy Laboratory, where he developed technology for the production of algal biofuels. Paul received an M.S. degree in Plant Physiology from Michigan State University and a Ph.D. in Biology from the University of Colorado, Boulder.

Algenol is a global industrial biotechnology company that is commercializing its patented DIRECT TO ETHANOL® algae technology, projected by the company to enable the production of ethanol for less than $1.00 per gallon using sunlight, carbon dioxide and saltwater, and which targets commercial production of 6,000 gallons of ethanol per acre per year. A pilot-scale integrated biorefinery project to demonstrate commercial viability of the process is under development in Fort Myers, Florida.

More Buzz…

Go to HOME Page

Copyright ©2010-2012 AlgaeIndustryMagazine.com. All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
Phys.org reports that, in collaboration with the Berlin, Germany LED manufacturer FutureLED, scientists at the Technische Universität München have developed a unique comb...
Tess Riley writes in TheGuardian.com about how spirulina may be able to combat malnutrition in developing countries. Spirulina is one of the oldest life forms on Earth, c...
Allan Koay writes in thestar.com about a Universiti Malaya research project paving the way for the commercial production of paper pulp and bioethanol from seaweed. The Al...
Much of the development of the algae industry in 2014 was driven by domestic and international alliances, partnerships, and mergers that brought complementary skills and ...
Green Star Products, Inc. (GSPI) has signed a contract to build a demonstration facility in Las Vegas, Nevada, to produce commercial quality algae. The Hybrid Algae Produ...
Fort Myers, FL-based Algenol, and India's Reliance Industries Ltd., have deployed India’s first Algenol algae production platform. The demonstration module is located nea...
Researchers Greg O’Neil of Western Washington University and Chris Reddy of Woods Hole Oceanographic Institution (WHOI), have exploited an unusual and untapped class of c...
In a recent study, published in PLOS ONE Journal, the influence of light intensity on the growth and lipid productivity of Nannochloropsis salina was investigated in a fl...
Developing renewable fuel from wet algae is one of the latest innovations Richland, Washington-based Pacific Northwest National Laboratory (PNNL) has successfully driven ...
Kailua Kona, Hawaii-based Cyanotech has announced financial results for the third quarter and first nine months of fiscal year 2015, ended December 31, 2014. For the thir...
Using a malaria parasite protein produced from algae, paired with an immune-boosting cocktail suitable for use in humans, researchers at UC San Diego School of Medicine g...
Solazyme has announced that total revenue for the fourth quarter of 2014 was $14.5 million, compared with $11.3 million in the fourth quarter of 2013, an increase of 29%....
As of March 1, 2015, bbi-biotech GmbH, of Berlin, Germany, has begun integrating IGV Biotech GmbH’s photobioreactors into its own life science product portfolio. A former...
None of us would be alive if sperm cells didn’t know how to swim, or if the cilia in our lungs couldn’t prevent fluid buildup. But we know very little about the dynamics ...
Sebastian Rich reports on PBS Newshour about the Central African Republic city of Bangui, which has been caught in the crossfire between warring Muslim and Christian grou...